IHC analysis of brain sections from the 5-day CCP treatment revealed a peripheral-NK cell-independent, CCP-evoked induction of MCP-1 within the GBM TAM (Additional file 11: Figure S11). The gene discussed is CCL2; the disease is glioblastoma.